"Receptors, LDL" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Receptors on the plasma membrane of nonhepatic cells that specifically bind LDL. The receptors are localized in specialized regions called coated pits. Hypercholesteremia is caused by an allelic genetic defect of three types: 1, receptors do not bind to LDL; 2, there is reduced binding of LDL; and 3, there is normal binding but no internalization of LDL. In consequence, entry of cholesterol esters into the cell is impaired and the intracellular feedback by cholesterol on 3-hydroxy-3-methylglutaryl CoA reductase is lacking.
Descriptor ID |
D011973
|
MeSH Number(s) |
D12.776.543.750.710.450
|
Concept/Terms |
Receptors, LDL- Receptors, LDL
- LDL Receptors
- LDL Receptors, Lipoprotein
- Receptors, Lipoprotein LDL
- Lipoprotein LDL Receptors
- Low Density Lipoprotein Receptors
- Receptors, Lipoprotein, LDL
- Receptors, Low Density Lipoprotein
- LDL Receptor
- Receptor, LDL
- Low Density Lipoprotein Receptor
|
Below are MeSH descriptors whose meaning is more general than "Receptors, LDL".
Below are MeSH descriptors whose meaning is more specific than "Receptors, LDL".
This graph shows the total number of publications written about "Receptors, LDL" by people in this website by year, and whether "Receptors, LDL" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1994 | 3 | 3 | 6 |
1995 | 1 | 0 | 1 |
1996 | 2 | 0 | 2 |
1997 | 2 | 0 | 2 |
1999 | 2 | 0 | 2 |
2000 | 1 | 1 | 2 |
2001 | 1 | 0 | 1 |
2002 | 0 | 2 | 2 |
2003 | 2 | 3 | 5 |
2004 | 2 | 1 | 3 |
2006 | 1 | 0 | 1 |
2007 | 3 | 1 | 4 |
2008 | 1 | 0 | 1 |
2009 | 4 | 3 | 7 |
2010 | 1 | 2 | 3 |
2011 | 2 | 1 | 3 |
2012 | 3 | 1 | 4 |
2013 | 0 | 2 | 2 |
2014 | 3 | 3 | 6 |
2015 | 4 | 2 | 6 |
2016 | 2 | 0 | 2 |
2017 | 2 | 1 | 3 |
2018 | 2 | 1 | 3 |
2019 | 0 | 3 | 3 |
2020 | 0 | 2 | 2 |
2021 | 1 | 1 | 2 |
2024 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Receptors, LDL" by people in Profiles.
-
Leukocyte immunoglobulin-like receptor B1 (LILRB1) protects human multiple myeloma cells from ferroptosis by maintaining cholesterol homeostasis. Nat Commun. 2024 Jul 09; 15(1):5767.
-
Greater than expected reduction in low-density lipoprotein-cholesterol (LDL-C) with bempedoic acid in a patient with heterozygous familial hypercholesterolemia (HeFH). J Clin Lipidol. 2021 Sep-Oct; 15(5):649-652.
-
Inhibition of low-density lipoprotein uptake by Helicobacter pylori virulence factor CagA. Biochem Biophys Res Commun. 2021 06 04; 556:192-198.
-
Involvement of Essential Signaling Cascades and Analysis of Gene Networks in Diabesity. Genes (Basel). 2020 10 25; 11(11).
-
Monosomy X in Female Mice Influences the Regional Formation and Augments the Severity of Angiotensin II-Induced Aortopathies. Arterioscler Thromb Vasc Biol. 2021 01; 41(1):269-283.
-
Epac1 (Exchange Protein Directly Activated by cAMP 1) Upregulates LOX-1 (Oxidized Low-Density Lipoprotein Receptor 1) to Promote Foam Cell Formation and Atherosclerosis Development. Arterioscler Thromb Vasc Biol. 2020 12; 40(12):e322-e335.
-
Phosphatidylinositol-(4,5)-Bisphosphate Regulates Plasma Cholesterol Through LDL (Low-Density Lipoprotein) Receptor Lysosomal Degradation. Arterioscler Thromb Vasc Biol. 2020 05; 40(5):1311-1324.
-
Coronary artery disease in a child with homozygous familial hypercholesterolemia: Regression after liver transplantation. J Clin Lipidol. 2019 Nov - Dec; 13(6):880-886.
-
Downregulation of circular RNA circ-LDLRAD3 suppresses pancreatic cancer progression through miR-137-3p/PTN axis. Life Sci. 2019 Dec 15; 239:116871.
-
Ticagrelor induces paraoxonase-1 (PON1) and better protects hypercholesterolemic mice against atherosclerosis compared to clopidogrel. PLoS One. 2019; 14(6):e0218934.